Piragliatin

Drug Profile

Piragliatin

Alternative Names: GK Activator (2); GK2; R1440; RO4389620

Latest Information Update: 18 Sep 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Roche
  • Class Antihyperglycaemics; Benzeneacetamides; Pyrazines; Small molecules
  • Mechanism of Action Glucokinase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 11 Sep 2008 Efficacy data from a phase II trial in Type 2 diabetes presented at the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD-2008)
  • 11 Sep 2008 Pharmacokinetics, pharmacodynamics and adverse events data from a phase I trial in Type 2 diabetes mellitus presented at the 44th Annual Meeting of the European Association for the Study of Diabetes (EASD-2008)
  • 23 Jul 2007 Discontinued - Phase-II for Type-2 diabetes mellitus in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top